Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Jul 22, 2015
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Class A Common Stock
2015-07-20$14.82/sh+45,000$666,900→ 45,000 total - Sale
Class A Common Stock
2015-07-20$23.43/sh−12,718$297,983→ 0 total - Sale
Class A Common Stock
2015-07-20$23.43/sh−6,810$159,558→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-07-20−6,810→ 228,840 totalExercise: $6.75From: 2015-03-31Exp: 2015-08-31→ Class A Common Stock (6,810 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2015-07-20−12,718→ 216,122 totalExercise: $6.75From: 2015-03-31Exp: 2015-08-31→ Class A Common Stock (12,718 underlying) - Exercise/Conversion
Class A Common Stock
2015-07-20$6.75/sh+6,810$45,968→ 6,810 total - Exercise/Conversion
Class A Common Stock
2015-07-20$6.75/sh+12,718$85,847→ 12,718 total - Sale
Class A Common Stock
2015-07-20$23.43/sh−45,000$1,054,350→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-07-20−45,000→ 235,650 totalExercise: $14.82From: 2015-03-31Exp: 2015-08-31→ Class A Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $24.03, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.